Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk

Seminars in Arthritis and Rheumatism
Atul A Khasnis, Leonard H Calabrese

Abstract

Tumor necrosis factor inhibitors (TNFi) are being increasingly used for a wide range of indications. There are increasing reports of pulmonary toxicity related to the use of TNFi. In this review, we have attempted to synthesize the available literature regarding noninfectious complications related to TNFi use. We reviewed case reports, case series, and clinical trials accessed from the PubMed database (www.pubmed.gov), European League Against Rheumatism web archive (http://www.abstracts2view.com/eular/index.php), and the British Society of Rheumatology Biologics Register Newsletter website (http://www.rheumatology.org.uk/publications) using 23 search terms. There are increasing data available about use of TNFi in treatment of systemic inflammatory rheumatologic disorders and their attempted use for various pulmonary indications. Currently reported noninfectious pulmonary complications related to TNFi use include most commonly granulomatous disease and pulmonary fibrosis/interstitial lung disease and rarely alveolar hemorrhage and antisynthetase syndrome. De novo granulomatous disease seems to be mostly reversible, whereas pulmonary fibrosis carries the worst prognosis especially in the setting of prior lung fibrosis. Serious an...Continue Reading

References

Oct 1, 1992·American Journal of Respiratory Cell and Molecular Biology·Y OhkawaraT Takishima
Jan 1, 1987·Journal of Cellular Physiology. Supplement·J VilcekJ Le
Jan 1, 1988·Transactions of the Royal Society of Tropical Medicine and Hygiene·J R SchiltzA A Mahmoud
Sep 1, 1993·Thorax·J GauldieG Cox
Feb 1, 1997·American Journal of Respiratory Cell and Molecular Biology·I BäumerJ Müller-Quernheim
Aug 18, 2000·Immunology and Cell Biology·B M Saunders, A M Cooper
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y Y LiA M Feldman
Jan 11, 2003·Arthritis and Rheumatism·Neil KramerElliot D Rosenstein
Aug 12, 2003·Arthritis and Rheumatism·Phillip A CourtneyE M Whitehead
Dec 4, 2003·Rheumatology·J MusiałM Celińska-Lowenhoff
Aug 5, 2004·Inflammatory Bowel Diseases·Sofia PanagiKlaus D Lessnau
Sep 17, 2004·Scandinavian Journal of Rheumatology·S Chatterjee
Oct 2, 2004·The European Respiratory Journal·E BargagliP Rottoli
Nov 27, 2004·BMJ : British Medical Journal·Andrew J K OstorDavid G I Scott
Mar 15, 2005·Chest·John D DotyMarc A Judson
Aug 6, 2005·Arthritis and Rheumatism·Kristine Phillips, Michael Weinblatt
Sep 17, 2005·Pharmacotherapy·David J Rychly, Joseph T DiPiro
Sep 24, 2005·International Archives of Allergy and Immunology·Axel TrautmannCezmi A Akdis
Oct 8, 2005·Clinical Rheumatology·Alexander RozinAlexandra Balbir-Gurman
Oct 26, 2005·Clinical Rheumatology·José Luis Callejas-RubioMaria Nicolas Benticuaga
Dec 13, 2005·American Journal of Respiratory and Critical Care Medicine·Cristina RussoRiccardo Polosa
Feb 8, 2006·Arthritis and Rheumatism·Abraham SchoeJacob M van Laar
Mar 2, 2006·Molecular Cell·Juan-Jose VenturaRoger J Davis
Apr 29, 2006·Arthritis and Rheumatism·Samy SuissaPierre Ernst
May 4, 2006·Inflammatory Bowel Diseases·Mark WeatherheadGraham P Burns
Jul 15, 2006·American Journal of Respiratory and Critical Care Medicine·Robert P BaughmanUNKNOWN Sarcoidosis Investigators
Jul 27, 2006·Southern Medical Journal·Anna Marie Quintos-Macasa, Robert Quinet
Aug 29, 2006·Rheumatology·M T Huggett, R Armstrong
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·Sheetal B Desai, Daniel E Furst
Oct 3, 2006·Arthritis and Rheumatism·Marcos A González-LópezVicente Rodríguez-Valverde
Dec 2, 2006·Arthritis and Rheumatism·Finbar D O'SheaRobert D Inman
Feb 20, 2007·Current Drug Targets. Inflammation and Allergy·Kian F Chung
Mar 7, 2007·Clinical Rheumatology·Kilian VerschuerenRene Westhovens
Apr 21, 2007·American Journal of Respiratory and Critical Care Medicine·Peter J Barnes

❮ Previous
Next ❯

Citations

Aug 13, 2014·Nature Reviews. Rheumatology·Onur BoymanFrançois Spertini
Nov 20, 2013·Heart & Lung : the Journal of Critical Care·Tarek AbdallahLouis Sasso
Jun 8, 2013·Chest·Fanny LanternierUNKNOWN Research Axed on Tolerance of Biotherapies Group
Jul 29, 2011·Reumatología clinica·Carlos Rodríguez Lozano
Jul 12, 2012·The Australasian Journal of Dermatology·Jessica Bale, Paul Chee
Jan 9, 2015·Chonnam Medical Journal·Sang Hoon KimSung Birm Sohn
Jan 25, 2017·Expert Opinion on Biological Therapy·Juan ChenXiaoming Liu
Mar 7, 2017·The Journal of Allergy and Clinical Immunology·Benjamin P Davis, Zuhair K Ballas
Jun 3, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Małgorzata PrzybyszewskaMaciej Małecki
Apr 19, 2018·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Alisson Aliel Vigano PugliesiMichel Alexandre Yazbek
Oct 4, 2018·Clinical Rheumatology·Bryant R EnglandTed R Mikuls
Aug 3, 2021·Experimental and Therapeutic Medicine·Irena PinteaDiana Deleanu
Jan 27, 2017·Journal of Medicinal Chemistry·Yi-Min LiuJing-Ping Liou
Nov 4, 2021·Future Medicinal Chemistry·Sabya Sachi DasKamal Dua

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.